Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

APYX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Apyx Medical Corporation logo

Apyx Medical Corporation

Sector: Healthcare   

Industry: Medical Instruments & Supplies

1.20
 
USD
  
0.01
  
(0.84%)
Previous close: 1.19  Open: 1.28  Bid: 1.15  Ask: 1.9
52 week range    
0.97   
   3.26
Mkt Cap: 42 M  Avg Vol (90 Days): 36,430
Peers   
NUVA / 
NVCN-CA / 
NURO / 
Last updated: Friday 11th October 2024

Stock Rankings

44
MarketXLS Rank
60
Value
23
Technical
50
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NUMD

NURO

0 B-14.15

NUVA

39.75

NVCN-CA

Financials

APYX Income Statement

Annual
Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends3 M932000.0
Amortization of intangibles0.0-100000.0-100000.0-100000.0
Basic EPS from continuing operations-0.4-1.03-0.14-0.77-0.58-0.35-0.44-0.67-0.54
Basic EPS total-0.4-1.03-0.14-0.51.89-0.58-0.35-0.44-0.67-0.54
Basic weighted shares outstanding17670.018 M27 M31 M33 M34 M34 M34 M35 M35 M
BasicDiscontinuousOperations0.272.21
Cost of sales14 M19 M19 M3 M-6 M9 M10 M15 M15 M19 M
Depreciation-734000.0-600000.0-400000.0-700000.0700000.0700000.0700000.0700000.0
DepreciationAndAmortization-734000.0-600000.0-400000.0-700000.0700000.0700000.0700000.0700000.0
Diluted EPS total-0.4-1.03-0.150.271.83-0.58-0.35-0.44-0.67-0.54
Diluted normalized net income/share-0.4-1.03-0.15-0.17-0.58-0.44-0.67-0.54
Diluted weighted shares outstanding17670.018 M27 M31 M34 M34 M34 M35 M35 M
DilutedDiscontinuousOperations0.272.14
Fees-543000.0
GainOnSaleOfSecurity-842000.0-7 M64000.0183000.020000.0
GainsLossOnDisposalOfDiscontinuedOperations0.068 M
GeneralAndAdministrativeExpense8 M8 M10 M10 M3 M9 M19 M26 M30 M29 M
Gross operating profit9 M9 M18 M7 M11 M19 M18 M34 M29 M34 M
Income before tax-6 M-13 M-4 M-14 M-15 M-20 M-19 M-15 M-23 M-21 M
Income restructuring and M&A0.02 M741000.0
Income taxes-2 M4 M64000.0-156000.0-4 M-130000.0-8 M380000.0367000.0-2 M
InterestExpenseNonOperating237000.0151000.0158000.0136000.0104000.08000.046000.010000.015000.02 M
InterestIncomeOperating0.0616000.01 M241000.011000.0157000.0921000.0
MinorityInterests10000.028000.094000.0137000.0
MiscOtherSpecialCharges-664000.011 M-415000.01 M200000.0-3 M
Net income from total operations-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M-19 M
NetIncomeCommonStockholders-7 M-18 M-4 M-14 M58 M-20 M-12 M-15 M-23 M-19 M
NetIncomeContinuousOperations-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M-19 M
NetIncomeDiscontinuousOperations68 M
NetNonOperatingInterestIncomeExpense-237000.0-151000.0-158000.0-136000.0-104000.0-8000.0-46000.0-10000.0-15000.0-2 M
NonRecurringOperationExpense2 M
Normalized income-24 M
Operating income-4 M-6 M-4 M-12 M-14 M-21 M-20 M-14 M-24 M-17 M
Operating income before depreciation (EBITDA)-5 M-12 M-3 M-13 M-14 M-19 M-18 M-14 M-22 M-18 M
OperatingExpense13 M15 M22 M19 M-25 M40 M38 M48 M53 M54 M
Other income net2 M7 M-64000.0-183000.0-20000.0-1 M-200000.03 M
OtherGandA8 M8 M10 M10 M3 M9 M19 M26 M30 M29 M
OtherOperatingExpenses0.0947000.0351000.0-479000.0373000.0-509000.0-3 M
OtherunderPreferredStockDividend3 M932000.0
PreferredStockDividends3 M932000.0
PromotionAndAdvertising0.0-700000.0-600000.0-800000.0-1 M800000.01 M2 M2 M
RentAndLandingFees-228000.0-72000.00.0
Research & development expense1 M1 M3 M2 M3 M4 M4 M4 M5 M5 M
ResearchExpense1 M1 M3 M2 M3 M4 M4 M4 M5 M5 M
RestructringAndMnAIncome0.02 M741000.0
Revenue per share-108000.0-100000.0-100000.0-100000.0-57000.0216000.0216000.0138000.031000.0
SalariesAndWages4 M6 M9 M7 M9 M14 M15 M18 M19 M20 M
Selling Gen & administrative expense8 M8 M10 M10 M13 M22 M19 M26 M30 M29 M
SellingAndMarketingExpense-305000.0-700000.0-600000.09 M14 M800000.01 M2 M2 M
SellingExpense9 M14 M
Special income/charges-2 M-2 M-741000.0
Total Income available for interest expense (EBIT)-6 M-13 M-4 M-14 M-15 M-20 M-19 M-15 M-23 M-19 M
Total common shares outstanding18 M18 M31 M33 M34 M34 M34 M34 M35 M35 M
Total net income-4 M-17 M-4 M-14 M58 M-20 M-12 M-15 M-23 M-19 M
Total ordinary shares35 M35 M35 M35 M35 M35 M35 M35 M35 M35 M
Total revenues24 M28 M37 M10 M17 M28 M28 M49 M45 M52 M
TotalExpenses27 M34 M40 M23 M-31 M49 M48 M63 M68 M72 M
TotalRevenue23 M28 M37 M10 M17 M28 M28 M49 M45 M52 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University